Trademark Overview
On Thursday, December 4, 2025, a trademark application was filed for ENCLOSE with the United States Patent and Trademark Office. The USPTO has given the ENCLOSE trademark a serial number of 99531114. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 4, 2025. This trademark is owned by New England Biolabs, Inc.. The ENCLOSE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:
Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; Chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; Enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; Chemicals, enzymes, nucleic acid constructs and viral vectors for scientific and research use; Nucleic acid constructs and viral vectors for use in the manufacture of nucleic acids; Nucleic acid constructs and viral vectors for manufacturing viruses; Nucleic acid constructs and viral vectors for use in scientific research, agribiotechnology, and nanotechnology; all of the aforementioned goods not for medical or veterinary use; Reagents for scientific or medical research use; Enzymes for scientific and research purposes; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with am...
Reagents for medical use; Reagents for medical purposes; Reagents for veterinary use; Chemical reagents for medical purposes; Biological reagents for medical purposes; Biological reagents for medical use; Chemical reagents for medical use; Enzymes for medical purposes; Nucleic acid constructs for medical and veterinary purposes; Nucleic acid constructs and viral vectors for use as prophylactic or therapeutic vaccines; Nucleic acid constructs and viral vectors for the production of prophylactic or therapeutic vaccines; Nucleic acid constructs and viral vectors for medical use; Nucleic acid constructs and viral vectors for the production of therapeutic or prophylactic viruses; Nucleic acid constructs and viral vectors for gene therapy; Nucleic acid constructs and viral vectors for use in cell therapy; Nucleic acid constructs and viral vectors for use in genome editing; Nucleic acid constructs and viral vectors for use in therapy